• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Intraoperative Injection of Intravitreal Dexamethasone Implant Using a Vitrectomy Trocar-Assisted Technique.

作者信息

Uwaydat Sami H, Wang Hans, Sallam Ahmed B

机构信息

Department of Ophthalmology, University of Arkansas for Medical Sciences, Little Rock, Arkansas. None of the authors has any conflicting interests to disclose.

出版信息

Retina. 2019 Oct;39 Suppl 1:S123-S124. doi: 10.1097/IAE.0000000000001853.

DOI:10.1097/IAE.0000000000001853
PMID:28991865
Abstract
摘要

相似文献

1
Intraoperative Injection of Intravitreal Dexamethasone Implant Using a Vitrectomy Trocar-Assisted Technique.使用玻璃体切割套管针辅助技术术中注射玻璃体内地塞米松植入剂
Retina. 2019 Oct;39 Suppl 1:S123-S124. doi: 10.1097/IAE.0000000000001853.
2
Thru-the-Trocar Administration of Dexamethasone Intravitreal Implant During 23-G Pars Plana Vitrectomy: A Small Case Series.23G经睫状体平坦部玻璃体切割术中经套管给予地塞米松玻璃体内植入物：一项小病例系列研究
Retina. 2015 Nov;35(11):2411-3. doi: 10.1097/IAE.0000000000000743.
3
Vitrectomy Combined with Intraoperative Dexamethasone Implant for the Management of Refractory Diabetic Macular Edema.玻璃体切除术联合术中地塞米松植入治疗难治性糖尿病性黄斑水肿
Korean J Ophthalmol. 2019 Jun;33(3):249-258. doi: 10.3341/kjo.2018.0100.
4
Minimally Invasive Microincision Vitrectomy Surgery with an Intraoperative Dexamethasone Implant for Refractory Diabetic Macular Edema.采用术中地塞米松植入的微创微小切口玻璃体切除术治疗难治性糖尿病性黄斑水肿
Ophthalmologica. 2016;235(3):150-6. doi: 10.1159/000443751. Epub 2016 Feb 24.
5
Dexamethasone intravitreal implant in the silicone oil-filled eye for the treatment for recurrent macular oedema associated with ankylosing spondylitis: a case report.地塞米松玻璃体内植入物用于治疗硅油填充眼中与强直性脊柱炎相关的复发性黄斑水肿：一例报告
Acta Ophthalmol. 2013 Jun;91(4):e331-2. doi: 10.1111/aos.12080. Epub 2013 Feb 11.
6
Pars plana vitrectomy and re-directing a dexamethasone implant into vitreous cavity following misdirected entry into the crystalline lens.经晶状体错误进入后行扁平部玻璃体切除术，并将地塞米松植入物重新引导至玻璃体腔。
Indian J Ophthalmol. 2018 Jul;66(7):1033-1036. doi: 10.4103/ijo.IJO_1179_17.
7
Treatment of Macular Edema after Pars Plana Vitrectomy for Idiopathic Epiretinal Membrane Using Intravitreal Dexamethasone Implant: Long-Term Outcomes.特立氟胺对多发性硬化症患者的疗效和安全性：一项荟萃分析。
Ophthalmologica. 2019;242(1):16-21. doi: 10.1159/000496705. Epub 2019 Mar 19.
8
COMBINED VITRECTOMY AND INTRAVITREAL DEXAMETHASONE (OZURDEX) SUSTAINED-RELEASE IMPLANT.玻璃体切除术联合玻璃体内地塞米松（Ozurdex）缓释植入物
Retina. 2016 Nov;36(11):2087-2092. doi: 10.1097/IAE.0000000000001063.
9
Intravitreal Sustained-Release Steroid Implants for the Treatment of Macular Edema following Surgical Removal of Epiretinal Membranes.玻璃体内缓释类固醇植入物用于治疗视网膜前膜手术切除后黄斑水肿
Ophthalmologica. 2017;237(4):232-237. doi: 10.1159/000464259. Epub 2017 May 3.
10
Use of intravitreal dexamethasone implant in patients with cataract and macular edema undergoing phacoemulsification.玻璃体内地塞米松植入物在白内障合并黄斑水肿患者行超声乳化术中的应用。
Eur J Ophthalmol. 2015 Mar-Apr;25(2):168-72. doi: 10.5301/ejo.5000523. Epub 2014 Oct 21.

引用本文的文献

1
Outcomes of intravitreal dexamethasone implant (Ozurdex) in patients with post-surgical macular edema - a real-world scenario.玻璃体内注射地塞米松植入剂（Ozurdex）治疗术后黄斑水肿患者的疗效——真实世界情况
Int J Retina Vitreous. 2025 Jan 10;11(1):4. doi: 10.1186/s40942-024-00626-5.
2
Intravitreal Dexamethasone Implant at the Time of Silicon Oil Removal to Treat Persistent Macular Edema after Rhegmatogenous Retinal Detachment Repair.硅油取出时玻璃体内注射地塞米松植入物治疗孔源性视网膜脱离修复术后持续性黄斑水肿
J Clin Med. 2023 Feb 20;12(4):1697. doi: 10.3390/jcm12041697.
3
Intravitreal Dexamethasone Implant as a Sustained Release Drug Delivery Device for the Treatment of Ocular Diseases: A Comprehensive Review of the Literature.
玻璃体内注射地塞米松植入剂作为一种用于治疗眼部疾病的缓释给药装置：文献综述
Pharmaceutics. 2020 Jul 26;12(8):703. doi: 10.3390/pharmaceutics12080703.